Samuel Rubinstein

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Topic: 
    Bispecific antibodies
    Date added: 
    04/03/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi
    Topic: 
    Isatuximab
    Date added: 
    04/03/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    LAVA Therapeutics
    Topic: 
    Drugs in development
    Date added: 
    04/03/2024
Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility